ðŸŽ¯ References

Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601â€“615 (2021).
Kyle Swanson, Parker Walther, Jeremy Leitz, Souhrid Mukherjee, Joseph C Wu, Rabindra V Shivnaraine, James Zou, ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries, Bioinformatics, Volume 40, Issue 7, July 2024, btae416, https://doi.org/10.1093/bioinformatics/btae416
Yang, H., et al. (2019). ADMETopt: A web server for ADMET optimization in drug design via scaffold hopping. Journal of Chemical Information and Modeling, 58(12), 2581â€“2591.
â€‹â€‹Zhang, L. et al. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved Î±-ketoamide inhibitors. Science, 368(6489), 409â€“412.
Owen, D. R. et al. (2021). An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science, 374(6575), 1586â€“1593.
NCBI Protein BLAST. https://blast.ncbi.nlm.nih.gov/Blast.cgi
SwissDock. http://www.swissdock.ch/
PubChem. https://pubchem.ncbi.nlm.nih.gov/
Protein Data Bank. https://www.rcsb.org/
Jalview. https://www.jalview.org/
ADMETlab AI. https://admetmesh.scbdd.com/
Neurosnap Inc. - Computational Biology Platform for Research. Wilmington, DE, 2022. https://neurosnap.ai/.
